TRUTAKNA® (atacicept) has been FDA approved for IgAN, click to learn more. FILSPARI® (sparsentan) has also been FDA approved for FSGS and more information is coming soon. Please visit our Patient Navigation tool for support.
Community Leader
Lisa has volunteered in various capacities with NephCure for over 18 years. Her kidney disease journey began 22 years ago when her daughter, Brianna, was diagnosed with Minimal Change Nephrotic Syndrome at only 2 years old. NephCure has been an amazing support system for over 20 years and Lisa is happy to give back to others who walk this challenging road.
NephCure Email: lisacimino@nephcurevolunteer.org
Massachusetts
NephCure is a registered non-profit (501c3) tax-exempt charitable organization. EIN # 38-3569922.
© Copyright 2024 NephCure, Inc. All rights reserved worldwide. NephCure, and the logo, are federally registered trademarks of NephCure, Inc.
EN 
ES 